Department of Radiation Oncology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China.
Int J Oncol. 2020 Oct;57(4):1072-1073. doi: 10.3892/ijo.2020.5113. Epub 2020 Aug 19.
Subsequently to the publication of the above paper, the authors have realized that the western blots featured in Fig. 5B were inadvertently copied across from Fig. 4B owing to an error made during the figure compilation process. The corrected version of Fig. 5 is featured on the next page, showing the correct data for the western blot analysis of the programmed death receptor ligand 1 level in radioresistant lung cancer cells under the specified experimental conditions. Note that these changes do not affect the interpretation of the data or the conclusions reported in this paper, and all the authors agree to this correction. The authors apologize to the Editor and to the readership of the Journal for any inconvenience caused. [the original article was published in International Journal of Oncology 53: 317-328, 2018; DOI: 10.3892/ijo.2018.4394].
在上述论文发表后,作者意识到,由于在制作图表过程中出现错误,图 5B 中的免疫印迹图是无意中从图 4B 复制过来的。下一页展示的是更正后的图 5,显示了在特定实验条件下,耐辐射肺癌细胞程序性死亡受体配体 1 水平的免疫印迹分析的正确数据。请注意,这些变化不会影响本文数据的解释或报告的结论,所有作者都同意这一更正。作者向编辑和期刊读者表示歉意,给他们带来了不便。[原始文章发表于《国际肿瘤学杂志》53:317-328, 2018;DOI: 10.3892/ijo.2018.4394]。